Published in Immunol Today on February 01, 1989
Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic gamma delta + T cells. Immunology (1994) 0.91
More speculations on specific suppression. Immunol Today (1989) 0.75
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med (1982) 5.09
Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J (1978) 4.29
Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood (2001) 3.66
The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol (2007) 3.51
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med (1984) 3.31
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
Immunological enhancement of rat kidney grafts. Lancet (1969) 2.73
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med (1980) 2.52
Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48
Structural model of HLA-DR1 restricted T cell antigen recognition. Cell (1988) 2.41
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain (1980) 2.36
Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol (2001) 2.20
Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease. Clin Endocrinol (Oxf) (2000) 2.19
Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain (1978) 2.19
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab (1997) 2.14
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling. Ann Oncol (2009) 2.13
Impairment of GH secretion in adults with primary empty sella. J Endocrinol Invest (2002) 2.09
Methodology-dependent variation in documentation of outcome predictors in out-of-hospital cardiac arrest. Acad Emerg Med (1995) 2.01
Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab (2000) 1.99
"Exon-shuffling" maps control of antibody- and T-cell-recognition sites to the NH2-terminal domain of the class II major histocompatibility polypeptide A beta. Proc Natl Acad Sci U S A (1985) 1.93
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase. J Clin Microbiol (2001) 1.92
Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. Br Med J (1976) 1.91
Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet (1976) 1.89
Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med (1979) 1.88
HLA and hepatitis B infection. Lancet (1994) 1.85
Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia (2004) 1.84
Effectiveness of bystander cardiopulmonary resuscitation and survival following out-of-hospital cardiac arrest. JAMA (1995) 1.83
Isolation of endothelial cells from murine tissue. J Immunol Methods (2000) 1.81
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1993) 1.80
Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation (1998) 1.79
Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab (2000) 1.75
B-lymphocyte alloantigens associated with multiple sclerosis. Lancet (1976) 1.73
Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1994) 1.69
The significance of the association between HLA and multiple sclerosis. Br Med Bull (1978) 1.65
Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest (2002) 1.65
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab (1999) 1.62
High prevalence of reflux symptoms in duodenal ulcer patients who develop gastro-oesophageal reflux disease after curing Helicobacter pylori infection. Dig Liver Dis (2001) 1.61
Histocompatibility antigens in diabetic identical twins. Lancet (1975) 1.59
Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab (1998) 1.58
Percutaneous computed tomography-guided ethanol injection in aldosterone-producing adrenocortical adenoma. Eur J Endocrinol (1995) 1.56
The molecular basis of alloreactivity. Immunol Today (1990) 1.56
Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain (1987) 1.54
Consensus statement: medical management of acromegaly. Eur J Endocrinol (2005) 1.54
Accuracy of a new monoclonal stool antigen test in post-eradication assessment of Helicobacter pylori infection: comparison with the polyclonal stool antigen test and urea breath test. Dig Liver Dis (2005) 1.52
Influence of defined incompatibilities and area of burn on skin-homograft survival in burned-subjects. Lancet (1969) 1.52
Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab (2001) 1.51
Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab (2000) 1.49
Guidelines for acromegaly management. J Clin Endocrinol Metab (2002) 1.48
Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Clin Endocrinol (Oxf) (2009) 1.46
Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation (2001) 1.46
Thy-1+ dendritic epidermal cells belong to the T-cell lineage. Proc Natl Acad Sci U S A (1987) 1.46
HLA matching and corneal grafting. Lancet (1976) 1.46
Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Br Med J (1974) 1.45
Dental caries and enamel defects in very low birth weight adolescents. Caries Res (2010) 1.44
Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol (2001) 1.44
Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response. J Immunol (1980) 1.44
Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System. New Microbiol (2002) 1.43
Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol (2001) 1.43
Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertil Steril (1996) 1.43
Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in humans. Eur Heart J (1997) 1.43
Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol (1990) 1.43
Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity. Transplantation (2000) 1.43
The immune response to allogeneic rat platelets; Ag-B antigens in matrix form lacking Ia. Eur J Immunol (1977) 1.42
NOD2/CARD15 in healthy relatives of IBD patients. Eur Rev Med Pharmacol Sci (2006) 1.41
Postinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow-derived progenitor cells expressing membrane-tethered anticoagulant fusion proteins. J Thromb Haemost (2006) 1.41
Different dysregulations in adrenal steroid biosynthesis as a prevalent cause of hyperandrogenism in women from southern Italy. Fertil Steril (1997) 1.40
The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. Clin Endocrinol (Oxf) (2000) 1.40
The orbital veins. Am J Ophthalmol (1967) 1.39
[Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus]. Minerva Med (1992) 1.39
Cardiac arrest witnessed by prehospital personnel: intersystem variation in initial rhythm as a basis for a proposed extension of the Utstein recommendations. Ann Emerg Med (1997) 1.39
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males. Eur J Endocrinol (1996) 1.39
The influence of sex upon the antibody response to an incompatible tumour. Immunology (1965) 1.38
Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg (1988) 1.38
Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol (2009) 1.37
Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab (1999) 1.36
A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry (1987) 1.35
Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures. Minim Invasive Neurosurg (2002) 1.35
Phytohaemagglutinin transformation of lymphocytes in burned patients. Transplantation (1971) 1.32
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Transformation of lymphocytes from patients awaiting cadaver renal transplants. Lancet (1976) 1.32
Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol (2000) 1.32
MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum (2005) 1.32
Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicans. J Immunol (1981) 1.31
Allorecognition. Am J Transplant (2001) 1.30
HLA-DRw4 and rheumatoid arthritis. Lancet (1979) 1.29
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology (1996) 1.28
Matching for HLA in transplantation. Br Med Bull (1978) 1.27
Enhancement of renal allografts in rats and man. Transplant Rev (1972) 1.27
Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells. J Immunol (1985) 1.26